Tag: Gedeon Richter

EMA accepted the resubmission for review of Neulasta biosimilar

STADA Arzneimittel AG was informed by Gedeon Richter Plc. that the European Medicines Agency (EMA) has accepted the regulatory resubmission of its proposed biosimilar to Amgen's Neulasta (pegfilgrastim).

Gedeon Richter-Rus invests 1.2 billion rubles to expand its facilities

gedeon richter
The Government of the Moscow region and CJSC Gedeon Richter-Rus signed an agreement to upgrade and expand the pharmaceutical production facilities